As noted by Arienti et al. [73], HBO shows promise in inhibiting proliferation, downregulating HIF1α expression, and reprogramming glucose metabolism, offering the potential for the systemic therapy of glioblastoma. This evidence concerns the gene HIF1A and glioblastoma.